A clinical trial to study the effects of Caripill drug on severely low platelet counts in patients with dengue disease
Phase 2
- Conditions
- Health Condition 1: null- Dengue
- Registration Number
- CTRI/2017/08/009579
- Lead Sponsor
- Micro Labs Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 84
Inclusion Criteria
1.Provide signed and dated informed consent form
2.Willing to comply with all study procedures and be available for the duration of the study
3.Male or female, aged greater than or equal to 18 yrs of age. Clinically diagnosed of dengue and a peripheral platelet count of less than or equal to 30,000/µL.
4.A laboratory positive diagnosis of dengue confirmed by a positive NS1 ELISA test and/or detection of viral RNA by real time PCR assay.
Exclusion Criteria
1.Pregnancy and lactation.
2.Patients who has been given steroids for thrombocytopenia and also those who have been transfused platelets before starting the drug
3.Taking indigenous medicines.
4.Creatine kinase (CK) >1000 U/L
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method